NCT04430634View on ClinicalTrials.gov

A Study to Evaluate Nicotine Uptake and Biomarkers in Smokers Using mybluTM Electronic Cigarettes

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Healthy Volunteers
Interventions
OTHER

Myblu variant A

Use of Myblu e-cigarette with flavor A 2.4% nicotine

OTHER

Myblu variant B

Use of Myblu e-cigarette with flavor B 3.6% nicotine

OTHER

Myblu variant C

Use of Myblu e-cigarette with flavor C 2.5% nicotine

OTHER

Myblu variant D

Use of Myblu e-cigarette with flavor D 4.0% nicotine

OTHER

Myblu variant E

Use of Myblu e-cigarette with flavor E 3.6% nicotine

OTHER

Myblu variant F

Use of Myblu e-cigarette with flavor F 2.4% nicotine

OTHER

Myblu variant G

Use of Myblu e-cigarette with flavor G 4.0% nicotine

OTHER

Myblu variant H

Use of Myblu e-cigarette with flavor H 3.6% nicotine

Trial Locations (1)

68502

Celerion, Lincoln

All Listed Sponsors
collaborator

Fontem Ventures BV

INDUSTRY

lead

Fontem US LLC

INDUSTRY

NCT04430634 - A Study to Evaluate Nicotine Uptake and Biomarkers in Smokers Using mybluTM Electronic Cigarettes | Biotech Hunter | Biotech Hunter